Fabry's disease presenting as syncope, angiokeratomas, and spoke-like cataracts in a young man: Discussion of the differential diagnosis

Military Medicine

Volumn 162, Issue 11, 1997, Pages 773-776

  Menkes, Daniel L ^a   O'Neil, Terrence J ^a   Saenz, Kristin K P ^a  

^a DAVID GRANT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDROCORTISONE ACETATE;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CASE REPORT; CATARACT; DIFFERENTIAL DIAGNOSIS; FABRY DISEASE; HEMANGIOKERATOMA; HUMAN; MALE; NEURALGIA; PATHOPHYSIOLOGY; RENOVASCULAR DISEASE; SKIN BIOPSY; SYNCOPE;

EID: 1842364879     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/162.11.773     Document Type: Article

References (39)

1. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981; 22: 489-501.
2. Wyllie E: The Treatment of Epilepsy: Principles and Practice, pp 359-68. Philadelphia, Lea and Febiger, 1993.
3. Schier RW, Gottschalk CW: Diseases of the Kidney, Ed 5, pp 65-119. Boston, Little Brown, 1993.
4. Zigman S: The role of sunlight in human cataract formation. Sun Ophthalmol 1983; 27: 317.
5. Urban RC, Cotlier E: Corticosteroid-induced cataracts. Sun Ophthalmol 1986; 31: 102.
6. Newell F: Ophthalmology: Principles and Concepts, p 362. Boston, Mosby, 1992.
7. Hamming NA, Apple DJ: Histopathology and ultrastructure of busulfan induced cataract. Graefe's Arch Clin Exp Ophthalmol 1976; 200: 139.
8. Cordes FC: Galactosemia cataract: a review. Am J Ophthalmol 1960; 50: 1151.
9. Collins J (ed): Ophthalmic Desk Reference, p 306. New York, Raven Press, 1991.
10. Brenner BM, Rector FC. The Kidney, Ed 4, pp 1280-369. Philadelphia, WB Saunders, 1991.
11. Konigsmark BW: Hereditary progressive cochleovestibular atrophies. In Handbook of Clinical Neurology, Vol 22, pp 499-526. Edited by Vinken PJ, Bruyn GW. Amsterdam, North-Holland, 1975.
12. Daly D, Pedley TA: Current Practice of Clinical Electroencephalography, Ed 2, p 391. New York, Raven Press, 1990.
13. Physicians' Desk Reference, Ed 50, p 1509. Montvale, NJ, Medical Economics, 1996.
14. Brady RO, Gal AE, Bradley RM, et al: Enzymatic defect in Fabry's disease: ceramidetrihexosidase deficiency. N Engl J Med 1967; 276: 1163.
15. Eng CM, Desnick RJ: Molecular basis of Fabry's disease: mutations and polymorphisms in the human galactosidase A gene. (Review.) Hum Mutat 1994; 3: 103-11.
16. Kornreich R, Desnick RJ: Fabry's disease: detection of gene rearrangements in the human alpha-galactosidase A gene by multiply PCR amplification. Hum Mutat 1993; 2: 108-11.
17. Brady R: Article title. In Peripheral Neuropathy, Ed 3, pp 1169-78. Edited by Dyck P, Thomas PK. Philadelphia, WB Saunders, 1993.
18. Imperial R, Helwig EB: Angiokeratoma: clinical pathology study. Arch Dermatol 1967; 95: 166.
19. Francois J, Hanssens M, Teuchy H: Corneal ultrastructural changes in Fabry's disease. Ophthalmologica 1978; 176: 313.
20. Pochis WT, Litaow JT, King BG, Kenny D: Electrophysiologic finding in Fabry's disease with a short PR interval. Am J Cardiol 1994; 74: 203-4.
21. Ikari Y, Kuwako K, Yamaguchi T: Fabry's disease with complete atrioventricular blocks: histologic evidence of involvement of the conduction system. Br Heart J 1992; 68: 323-5.
22. Lockman LA, Krivit W, Desnick RJ: Relief of the painful crises of Fabry's disease by diphenylhydantoin. Neurology 1971; 21: 423.
23. Filling-Katz MR, Merrick HF, Fink JK, et al: Carbemazepine in Fabry's disease: effective analgesia with dose dependent exacerbation of autonomic dysfunction. Neurology 1989; 29: 598.
24. Grewal RP: Stroke in Fabry's disease. J Neurol 1994; 241(3): 153-6.
25. Dvorak AM, Cable WJL, Osage JE, et al: Diagnostic electron microscopy in Fabry's disease: use of biopsies from uninvolved skin. Acute and chronic changes involving the microvasculature and uninvolved nerves. Pathol Annu 1981; 16: 139.
26. Rae AI, Lee JC, Hopper J: Clinical and electron microscopic studies of a case of glycolipid lipidosis (Fabry's disease). J Clin Pathol 1967; 20: 21.
27. Sagebiel RW, Parker F: Cutaneous lesions of Fabry's disease: glycolipid lipidosis and light and electron microscopic findings. J Invest Dermatol 1968; 50: 208.
28. Brady RO, Tallman FJ, Johnson WG, et al: Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease. N Engl J Med 1973; 789: 9.
29. Lapins J, Emtestam L, Marcusson JA: Angiokeratomas in Fabry's disease and Fordyce's disease: successful treatment with a copper vapour laser. Acta Dermato-Venereol 1993; 73: 133-5.
30. Desnick RJ, Simmons RL, Allen KY, et al: Correction of enzymatic deficiencies by renal transplantation: Fabry's disease. Surgery 1972; 72: 203.
31. Gantenbein M, Bruder E, Burger HR, et al: Recurrence of Fabry's disease in a renal allograft 14 years after transplantation. Nephrol Dial Transplant 1995; 10: 287-9.
32. Mosnier JF, Degolt C, Bedrussian J, et al: Recurrence of Fabry's disease in a renal allograft eleven years after successful renal transplantation. Transplantation 1991; 51: 759-67.
33. Brady RO, Uhlendorf BW, Jacobson CB: Fabry's disease: antenatal detection. Science 1971; 172: 174.
34. Kleijer WJ, Hussaarts-Odijk LM, Sachs ES, et al: Prenatal diagnosis of Fabry's disease by direct analysis of chorionic villi. Prenatal Diagn 1987; 7: 283.
35. Bannister R: Treatment of autonomic failure. (Review.) Current Opinion in Neurology and Neurosurgery 1992; 5: 487-91.
36. Jerian SM, Sarosy GA, Link CJ, et al: Incapacitating neuropathy precipitated by taxol. Gynecol Oncol 1993; 51: 277-80.
37. Ten Harkel AD, Van Lieshout JJ, Wieling W: Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone. J Intern Med 1992; 232: 139-45.
38. Balaji S, Oslizlok PC, et al: Neurocardiogenic syncope in children with a normal heart. J Am Coll Cardiol 1994; 23: 779-85.
39. Lathers CM, Charles JB: Orthostatic hypotension in patients, bed rest subjects and astronauts. (Review.) J Clin Pharmacol 1994; 34: 403-17.